Treatment of Resistant Depression by Repetitive Transcranial Magnetic Stimulation (rTMS) Multicentric Naturalistic Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-18

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Repetitive Transcranial Magnetic Stimulation (rTMS) for repetitive Transcranial Magnetic Stimulation) is a a recent technique to stimulate the brain in a way that non-invasive, for therapeutic purposes. The first trials of analgesic use of rTMS date back to about 15 years ago. years and clinical use has now entered the practice of some specialized centers. Used at a frequency less than or equal to 1 Hertz (Hz; a stimulation per second), it is called bass rTMS. frequency and results in inhibition of cortical excitability at the level of the stimulated area. Conversely, a stimulation with a frequency higher than 5 Hz, called high-frequency rTMS, will have an excitatory effect on the targeted neurons. In addition to its local effects at the stimulation site, rTMS can also have effects on distance on regions other than those directly targeted. The impact of this treatment would be the local modulation of the cerebral plasticity and also act on the anatomical connectivity and functional brain function in both healthy subjects and those who are patients with psychiatric disorders

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Electroencephalography-based Precise Repetitive Transcranial Magnetic Stimulation Treatment

NCT06385405

Major Depressive Disorder (MDD)

RECRUITING NA

Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive Disorder

NCT00104611

Major Depressive Disorder

COMPLETED PHASE3

Feasibility and Efficacy of rTMS in Healthy Persons

NCT04074811

Executive Dysfunction Pain Mood

WITHDRAWN NA

Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders

NCT00001545

Bipolar Disorder Mood Disorder Unipolar Depression

COMPLETED PHASE2

Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation

NCT06429748

Neurologic Symptoms

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Main objective :

To show the effectiveness of rTMS carried out in open on the symptoms of depression resistant in common practice between the Baseline and the end of the initial treatment (between 1 and 6 weeks).

Secondary Objectives

Evaluate the tolerance of the rTMS carried out in open on the symptoms of depression resistant in common practice between the Baseline and the end of the initial cure (between 1 and 6 weeks)

Evaluate the impact of this treatment on :

* The response rate
* The remission rate
* Quality of life To assess the correlation between personality dimensions and depression.

The criteria main evaluation :

The evolution of the HDRS-17 score (Hamilton depression scale, 17 items) between the Baseline and the end of the initial treatment (1 to 6 weeks)

The evaluation criteria secondary :

* Responder patient rate (defined as a 50% decrease in the rate of

% of HDRS score)
* Rate of patients in remission (defined by HDRS score\<8)
* Evolution of the EQ5D quality of life score between Baseline and end of the initial treatment (between 1 and 6 weeks)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

To Evaluate the Effectiveness of Open rTMS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Multicentric Naturalistic Study

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

rTMS basic

1 session per day, for 4 or 6 weeks.

Intervention Type DEVICE

rTMS VIIT

5 sessions per day, for 2 weeks.

Intervention Type DEVICE

rTMS SAINT modified

8 sessions per day, for 1 week.

Intervention Type DEVICE

rTMS SAINT

10 sessions per day, for 1 week.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Presenting a depressive episode characterized as resistant according to the DSM 5 criteria
* resistance is characterized by: non-response to at least two different antidepressants prescribed at effective doses for a duration greater than or equal to 6 weeks.
* Patient who agrees to participate in the study and who has signed an informed consent.
* Patient fluent in French
* Affiliation to a social security scheme.
* Women of childbearing age must be on contraception

Exclusion Criteria

* Presenting a contraindication to TMS: intrafemale foreign body cranial, unstable epilepsy, cochlear implant, pacemaker, pregnancy
* Presence of a psychotic disorder
* Presence of an unstable medical condition
* Presence of schizophrenia or persistent delusional disorder
* Persons under guardianship, curatorship and safeguarding of justice.
* Pregnant women,
* Woman of childbearing age without effective contraception
* Breastfeeding woman

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No